Resources
Understanding placebos and comparison groups
Many cancer clinical trials compare one group of participants with another. Once you know how that comparison works, you are better placed to decide whether a study is right for you, or for the person you are reading for.
Updated
What a placebo is
A placebo is a substance with nothing active in it, made to resemble the product a cancer study is testing. When researchers compare the two groups, they can see what difference the investigational product actually makes.
How groups are assigned
Chance often decides which group a participant joins. This is called randomization. In some cancer studies, you and the study team are both kept from knowing your group until the study ends, and that is called blinding. It is there so that expectations do not affect the results.
What you are told in advance
The consent document covers this in writing. It tells you whether a placebo may be used, how likely each group is, and whether existing care continues alongside the study. If you are reading for a family member, these are the same points to look for. Read about the phases of a clinical trial.
Talk with a study coordinator
A coordinator at Oncology Research Hub can explain which cancer studies may fit and what the next step looks like. Call (888) 343-1186 or send a short form, for yourself or for someone you care for. Asking questions commits you to nothing.
Sources and further reading
- Glossary of Common Site Terms — ClinicalTrials.gov (National Library of Medicine)
- What Are Clinical Trials and Studies? — National Institute on Aging (NIH)